Pharmaron is a global pharmaceutical CRO/CDMO headquartered in Beijing, China, with numerous facilities in China, the U.S., and the UK. Founded in 2004, the company supports full drug discovery, preclinical, clinical, and commercial development process across small molecules, biologics, and viral vectors. Pharmaron’s capabilities include GMP API and AAV manufacturing, gene therapy development, plasmid production, cell line development, and cell banking, alongside advanced chemistry expertise such as asymmetric hydrogenations, air- and moisture-sensitive reactions, transition metal catalysis, and high- and low-temperature processes.